Your browser doesn't support javascript.
loading
A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1).
Bilusic, Marijo; Toney, Nicole J; Donahue, Renee N; Wroblewski, Susan; Zibelman, Matthew; Ghatalia, Pooja; Ross, Eric A; Karzai, Fatima; Madan, Ravi A; Dahut, William L; Gulley, James L; Schlom, Jeffrey; Plimack, Elizabeth R; Geynisman, Daniel M.
Affiliation
  • Bilusic M; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. mbilusic@gmail.com.
  • Toney NJ; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, 33136, USA. mbilusic@gmail.com.
  • Donahue RN; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Wroblewski S; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Zibelman M; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Ghatalia P; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
  • Ross EA; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
  • Karzai F; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
  • Madan RA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Dahut WL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Schlom J; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Plimack ER; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Geynisman DM; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Prostate Cancer Prostatic Dis ; 25(4): 735-740, 2022 04.
Article in En | MEDLINE | ID: mdl-35079115
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Metformin Type of study: Observational_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Metformin Type of study: Observational_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2022 Type: Article Affiliation country: United States